Lead Product(s) : Emodin
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : PoloMar Health
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The collaboration aims to investigate Emodin, an orally bioavailable selective P2X7 inhibitor, available as a component in a number of over-the-counter nutritional supplements, in a clinical program as a potential treatment for patients with autism spect...
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 08, 2023
Lead Product(s) : Emodin
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : PoloMar Health
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?